E-DRUG Archives (by date)

• Thread Index

March 31, 2000
• [e-drug] Re: Rules for advertising of medicines
  • From: "Greg Perry" <EGA2@csi.com>
• [e-drug] Re: Rules for advertising of medicines (cont'd)
  • From: "Dr.L.Offerhaus" <lo@EURONET.NL>
• [e-drug] Re: Wall Street Journal on expired drug (cont'd)
  • From: Beverley Snell <bev@burnet.edu.au>
• [e-drug] Re: Rules for advertising of medicines (cont'd)
  • From: "Charles Medawar" <charles@socialaudit.org.uk>
• [e-drug] Re: Rules for advertising of medicines (cont'd)
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• [e-drug] Re: Wall Street Journal on expired drug (donations) (cont'd)
  • From: JBRusso@aol.com
March 30, 2000
• [e-drug] Re: Wall Street Journal on expired drug (donations)
  • From: "Scott D.Hillstrom" <scott.hillstrom@analyticorp.co.nz>
• [e-drug] Rules for advertising of medicines - information needed
  • From: Vanda Zidoniene <VandaZidoniene@VVKT.LT>
• [e-drug] (Thailand) Inexpensive pills will be on sale soon
  • From: James.Love[love@cptech.org]
• [e-drug] Wall Street Journal on expired drug (donations)
  • From: "Mark Raijmakers, Wemos" <mark.raijmakers@wemos.nl>
March 29, 2000
• [e-drug] Re: Drug price mechanisms - request for information (cont'd)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
March 28, 2000
• [e-drug] Re: Article on The Global Drug Gap by Michael Reich
  • From: bfunda@echohealth.org.uk
• [e-drug] Re: Popular heartburn drug to be withdrawn in the U.S. (cont'd)
  • From: HINDU PHARMACY <pharmhin@goa1.dot.net.in>
• [e-drug] Re: Popular heartburn drug to be withdrawn in the U.S. (cont'd)
  • From: "Takeo Saio" <saio@ppp.bekkoame.ne.jp>
• [e-drug] Re: Drug Pricing policies in Spain
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
March 27, 2000
• [e-drug] Drug price mechanisms - request for information
  • From: "Philippine National Drug Policy Program" <ndp@doh.gov.ph>
March 26, 2000
• [e-drug] Shortages of drugs
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Act Up-Paris: Pharmacia & Upjohn is outlaw
  • From: myhr@online.no
• [e-drug] Drug Pricing policies in Spain
  • From: "Ellen 't Hoen" <ethoen@compuserve.com>
March 24, 2000
• [e-drug] Popular heartburn drug to be withdrawn in the U.S.
  • From: AHMADS@cder.fda.gov
• [e-drug] Pfizer weighs request to cut price of Fluconazole
  • From: Daniel_BERMAN@geneva.msf.org
March 23, 2000
• [e-drug] Re: U.S. FDA Pulls Troglitazone From the Market
  • From: "Takeo Saio" <saio@ppp.bekkoame.ne.jp>
March 22, 2000
• [e-drug] Pfizer aims to destroy Australian PBS (cont'd)
  • From: "SANTOSO, Mr B. (WPRO)" <SANTOSOB@who.org.ph>
• [e-drug] U.S. FDA Pulls Troglitazone From the Market
  • From: AHMADS@cder.fda.gov
• [e-drug] Article on The Global Drug Gap by Michael Reich
  • From: "Richard Laing" <richardl@bu.edu>
March 21, 2000
• [e-drug] Pharmacology Computer Simulations
  • From: Murray Bailey <murray_b@fsm.ac.fj>
• [e-drug] ACT UP Phila re "ACT UP" San Francisco
  • From: Asia.Russell[asia@CritPath.Org]
• [e-drug] Pfizer aims to destroy Australian PBS (cont'd)
  • From: "Dr. Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Generics and cost savings
  • From: Wilbert Bannenberg <73377.3055@compuserve.com>
March 20, 2000
• [e-drug] SUMA - The humanitarian supply management project
  • From: myhr@online.no
• [e-drug] MSF Press Conference on TB
  • From: "Ellen 't Hoen" <ethoen@compuserve.com>
• [e-drug] ACT UP Warns U.N. About AIDS Mistake
  • From: ACTUPSF@aol.com
March 19, 2000
• [e-drug] WHO Management Changes [2]
  • From: e-drug@usa.healthnet.org
• [e-drug] WHO/EDM Management Changes
  • From: e-drug@usa.healthnet.org
March 18, 2000
• [e-drug] SA Northern Province floods & donations (cont'd)
  • From: JBRusso@aol.com
• [e-drug] Compulsory license of fluconazole
  • From: druginfo@healthlink.org.za
March 17, 2000
• [e-drug] New Emergency Health Kit
  • From: myhr@online.no
• [e-drug] SA Northern Province floods & donations (cont'd)
  • From: "Scott D.Hillstrom" <scott.hillstrom@analyticorp.co.nz>
March 16, 2000
• [e-drug] SA Northern Province floods & donations (cont'd)
  • From: Anthony Battersby <FBA@compuserve.com>
• [e-drug] SA Northern Province floods & donations (cont'd)
  • From: Carmen.PEREZ@madrid.msf.org
• [e-drug] A Trip(s) in Brave New World of Drugs
  • From: Gerard.Requin
• [e-drug] SA Northern Province floods & donations
  • From: Danie Meyer <DMeyer@nphw.nt.healthlink.org.za>
March 15, 2000
• [e-drug] Improving access to antiretroviral drugs thesis by Helena Anna
  • From: "Richard Laing" <richardl@bu.edu>
• [e-drug] HIV/AIDS newsletter for Developing Countries
  • From: Leela McCullough <leela@usa.healthnet.org>
• [e-drug] Announcement workshop on drug metabolism for Africa
  • From: "Andrew Walubo" <waluboa@frm.uovs.ac.za>
• [e-drug] Problem-based pharmacotherapy training (cont'd)
  • From: hollowayk@who.ch
• [e-drug] Ensuring access to essential drugs in Africa
  • From: Victor Adefela <adefelav@whoafr.org>
March 14, 2000
• [e-drug] European Voice on Access to drugs
  • From: "Ellen 't Hoen" <ethoen@compuserve.com>
• [e-drug] 3rd Essential Drug Programme Managers meeting for Africa
  • From: Victor Adefela <adefelav@whoafr.org>
• [e-drug] MSF/TAC Fluconazole Compulsory License campaign
  • From: Daniel Berman <Daniel_BERMAN@geneva.msf.org>
March 13, 2000
• [e-drug] Prices of Essential Drugs in developing countries (cont'd)
  • From: Kris Weerasuriya <kw_twcp@slt.lk>
March 09, 2000
• [e-drug] Flood drug kits in Northern Province, South Africa (cont'd)
  • From: Julia Valderrama <juliav@bu.edu>
• [e-drug] Undergraduate pharmacotherapy teaching (cont'd)
  • From: hollowayk@who.ch
• [e-drug] Announcement Groningen Summer Course 2000
  • From: "W.Sloof" <w.sloof@med.rug.nl>
• [e-drug] Re: Evidence-based treatment guidelines (cont'd)
  • From: Yvonne Melia <ymelia@nuffieldfoundation.org>
• [e-drug] Flood drug kits in Northern Province, South Africa
  • From: Danie Meyer <DMeyer@nphw.nt.healthlink.org.za>
March 08, 2000
• [e-drug] Immunisation safety
  • From: Kirsten.Myhr[myhr@online.no]
• [e-drug] Injection safety
  • From: Kirsten.Myhr[myhr@online.no]
• [e-drug] Awareness raising on drug donations
  • From: "Mark Raijmakers, Wemos" <mark.raijmakers@wemos.nl>
March 07, 2000
• [e-drug] EU documents on access/IPR
  • From: Thiru Balasubramaniam <thiru@cptech.org>
• [e-drug] Performance Based Reimbursement of Health Services
  • From: "Peter Sipe" <psipe@msh.org>
• [e-drug] Re: Evidence based guidelines (cont'd)
  • From: "Leesette Turner" <hamis@iafrica.com>
• [e-drug] Prices of Essential Drugs in developing countries (cont'd)
  • From: Bonnie Fundafunda <bfunda@echohealth.org.uk>
March 06, 2000
• [e-drug] TBnet (00230) Q&A: Improving compliance (cont'd)
  • From: John Urquhart <urquhart@ix.netcom.com>
• [e-drug] TBnet (00230) Q&A: Improving compliance (cont'd)
  • From: "Manjit Kaur" <manjitk@echohealth.org.uk>
• [e-drug] Controlled Trials database - new registers
  • From: cctrials@cursci.co.uk
• [e-drug] Canada loses patent case; higher drug prices feared
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
March 04, 2000
• [e-drug] Re: EDL from Mozambique (cont'd)
  • From: Oliver Hazemba <ohazemba@zamnet.zm>
March 03, 2000
• [e-drug] Course Announcement: Managing Drug Supply for Primary Health Care
  • From: "MARIA MIRALLES" <MMIRALLES@msh.org>
• [e-drug] Undergraduate pharmacotherapy teaching (cont'd)
  • From: Abdul Rahman Noor <arnoor@pc.jaring.my>
• [e-drug] What motivates drug donations? (cont'd)
  • From: David Nelson <dnelson@ECNET.ec>
• [e-drug] Prices of Essential Drugs in developing countries (cont'd)
  • From: Bonnie Fundafunda <bfunda@echohealth.org.uk>
• [e-drug] EDL from Mozambique (cont'd)
  • From: Tom Moore <tmoore@msh.org>
• [e-drug] Evidence based guidelines (cont'd)
  • From: Sam Tornquist <adpc@netnam.org.vn>
• [e-drug] SA Government Statement on Expert Panel for HIV/AIDS
  • From: Dr Ian Roberts <irobmoh@icon.co.za>
March 02, 2000
• [e-drug] Adrenalin - epinephrine (cont'd)
  • From: Stein Lyftingsmo <sjappe@apotek.no>
• [e-drug] Evidence based guidelines (cont'd)
  • From: Philippa Saunders <edp@gn.apc.org>
• [e-drug] EDL from Mozambique (cont'd)
  • From: Albert Petersen <amh@cityinfonetz.de>
• [e-drug] Cape Town meeting on new TB drugs (2)
  • From: Dermot Maher <D-Maher@dfid.gov.uk>
March 01, 2000
• [e-drug] Evidence based guidelines
  • From: Stephen Lonsdale <steve@slonsdale.freeserve.co.uk>
• [e-drug] TBnet (00230) Q&A: Improving compliance (cont'd)
  • From: John Urquhart <urquhart@ix.netcom.com>
• [e-drug] EDL from Mozambique
  • From: Natalia Herce <nherce@unav.es>
• [e-drug] TBnet (00230) Q&A: Improving compliance
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] What motivates drug donations? (cont'd)
  • From: Timothy Dodd <Cath_and_Tim_Dodd@compuserve.com>
• [e-drug] What motivates drug donations? (cont'd)
  • From: Regine Seer <Regineseer@aol.com>
• [e-drug] Cost of clinical trials
  • From: Chandresh Harjivan <harjivan@hotmail.com>